Mandatum Life Insurance Co Ltd Acquires New Stake in GE HealthCare Technologies Inc. $GEHC

Mandatum Life Insurance Co Ltd bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 100,037 shares of the company’s stock, valued at approximately $7,513,000. GE HealthCare Technologies accounts for 1.8% of Mandatum Life Insurance Co Ltd’s holdings, making the stock its 11th biggest holding.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Wedge Capital Management L L P NC bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,859,000. Valicenti Advisory Services Inc. increased its position in shares of GE HealthCare Technologies by 22.6% during the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after acquiring an additional 12,550 shares during the last quarter. Locust Wood Capital Advisers LLC lifted its holdings in GE HealthCare Technologies by 7.1% during the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after acquiring an additional 137,992 shares during the period. Nan Fung Trinity HK Ltd. bought a new stake in GE HealthCare Technologies during the third quarter worth $23,206,000. Finally, National Bank of Canada FI boosted its position in GE HealthCare Technologies by 133.3% in the second quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock worth $66,640,000 after purchasing an additional 514,007 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on GEHC shares. Piper Sandler raised their target price on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. The Goldman Sachs Group restated a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Evercore boosted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Citigroup increased their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Finally, BTIG Research lifted their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Stock Down 1.9%

GEHC opened at $79.08 on Tuesday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a market cap of $36.04 billion, a PE ratio of 17.34, a price-to-earnings-growth ratio of 1.75 and a beta of 1.09. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The company has a 50 day moving average of $82.73 and a 200 day moving average of $77.57.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. During the same period in the prior year, the business posted $1.45 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.